↓
 

Monthly Archives: March 2019

Dr. Giorgio Scagliotti: Shaping the Transformation of Thoracic Oncology

Drs. Jack West & Giorgio Scagliotti discuss the rapid evolution of lung cancer management as well as the practical bottlenecks & challenges limiting the quality of lung cancer care globally. (17:42)

Dr. Alex Drilon: Clinical Research and the Changing Practice of Managing Molecularly-Defined, Narrow Subgroups

Drs. Jack West & Alex Drilon, from Memorial Sloan-Kettering, discuss opportunities & challenges of studying narrow molecularly-defined patient subgroups, (MET, RET, TRK, & others), along with the increasingly active role of online patient groups. (12:17)

Drs. Christine Hann & Stephen Liu: Moving the Needle in Small Cell Lung Cancer

Dr. Jack West & guests, Drs. Christine Hann from Johns Hopkins & Stephen Liu from Georgetown, review recent potentially practice-changing results in small cell lung cancer (SCLC) & consider the challenges & future prospects for the SCLC landscape. (23:45)

Dr. Matthew Gubens: Integration of Teleoncology into Clinical Practice, Mounting Data on Plasma NGS, & Preserving Work-Life Balance

Dr. Jack West connects with Dr. Matthew Gubens of UCSF, discussing practicing oncology in the Bay Area, telemedicine in the cancer clinic, emerging data supportig plasma NGS in advanced NSCLC, & struggling to maintain work-life balance. (20:57)

Dr. Joan Schiller: Changes in lung cancer management, leading a nonprofit, addressing stigma, & the rise of online patients

Drs. Jack West & Joan Schiller discuss explosive changes in treating lung cancer, her role in developing a thriving nonprofit, challenges for women in academic medicine, stigma vs. lung cancer patients, & the growing influence of online patient groups. (19:07)

Dr. David Gandara: Cultivating Careers, Shaping Clinical Cancer Research, & Integrating Blood-Based Testing

Dr. Jack West speaks with thoracic oncology global leader, Dr. David Gandara, on his role in mentoring junior colleagues, the evolution of clinical trials under his leadership of the Lung Cancer Committee of SWOG, & the new opportunities presented by blood-based testing for biomarkers. (22:30)

Dr. David Spigel, Part 2: Identifying the Optimal Duration for Immunotherapy in Responding Patients with Advanced Lung Cancer

Dr. Jack West interviews Dr. David Spigel of Sarah Cannon Research Institute on the challenges of conducting clinical trials and delivering increasingly complex patient care, along with the possible future role of artificial intelligence and telemedicine. (20:36)

Dr. David Spigel, Part 1: Clinical Research and the Growing Complexity of Cancer Care in a Community Setting

Dr. Jack West interviews Dr. David Spigel of Sarah Cannon Research Institute on the challenges of conducting clinical trials and delivering increasingly complex patient care, along with the possible future role of artificial intelligence and telemedicine. (24:32)

↑